Journals / Cukurova Medical Journal / 2020 / Cilt: 45 - Sayı: 2

Plasma expression and methylation levels of vascular endothelial growth factor (VEGF-C) and basic fibroblast growth factor (bFGF) in children with acute lymphoblastic leukemia in Çukurova Region, Turkey

Çukurova Bölgesinde akut lenfoblastik lösemili çocuklarda vasküler endotelyal büyüme faktörü (VEGF-C) ve temel fibroblast büyüme faktörü (bFGF) plazma ekspresyonu ve metilasyon seviyeleri

Pages
581–587
Publication Date
2020-06-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further studies are required to establish strong links with both VEGF-C and bFGF, and ALL risk factors.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: The aim of this study was to determine the expression and methylation levels of vascular endothelial growth factor-C (VEGF-C) and basic fibroblast growth factor (bFGF) in children with acute lymphoblastic leukemia (ALL).Materials and Methods: We detected mRNA expression profiles and methylation levels of VEGF-C and bFGF genes in the peripheral blood samples of 26 patients with newly diagnosed ALL and 26 healthy controls by real-time quantitative PCR.
📊
Key Findings & Data:Results: The expression level of bFGF was significantly increased (4.23-fold) in ALL patients as compared with controls.
💡
Conclusion & Impact:Further studies are required to establish strong links with both VEGF-C and bFGF, and ALL risk factors.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:acute lymphoblastic leukemia · basic fibroblast growth factor · gene expression

Abstract

Purpose: The aim of this study was to determine the expression and methylation levels of vascular endothelial growth factor-C (VEGF-C) and basic fibroblast growth factor (bFGF) in children with acute lymphoblastic leukemia (ALL).Materials and Methods: We detected mRNA expression profiles and methylation levels of VEGF-C and bFGF genes in the peripheral blood samples of 26 patients with newly diagnosed ALL and 26 healthy controls by real-time quantitative PCR. Results: The expression level of bFGF was significantly increased (4.23-fold) in ALL patients as compared with controls. Moreover, VEGF-C were significantly decreased (3.41-fold) in ALL patients as compared with controls. The methylation of the promoter region of VEGF-C (6.88%) and bFGF (16.64%) genes was higher in ALL patients than in healthy controls. Conclusion: Long-term changes in VEGF-C and bFGF at different time intervals as a result of years of follow-up of patients may show stronger associations with disease risk. Further studies are required to establish strong links with both VEGF-C and bFGF, and ALL risk factors.

Özet

Amaç: Bu çalışmanın amacı akut lenfoblastik lösemili (ALL) çocuklarda vasküler endotel büyüme faktörü-C (VEGF-C) ve temel fibroblast büyüme faktörünün (bFGF) ekspresyon ve metilasyon düzeylerini belirlemekti.Gereç ve Yöntem: Gerçek zamanlı kantitatif PCR ile yeni tanı almış olan 26 hasta ve 26 sağlıklı kontrolün periferik kan örneklerinde VEGF-C ve bFGF genlerinin mRNA ekspresyon profilleri ve metilasyon seviyelerini tespit ettik.Bulgular: bFGF ekspresyon seviyesi ALL hastalarında kontrollere kıyasla anlamlı derecede artmıştı (4.23 kat). Ayrıca, VEGF-C ALL hastalarında kontrollere kıyasla anlamlı derecede azalmıştı (3.41 kat). VEGF-C (%6.88) ve bFGF (%16.64) genlerinin promotor bölgelerinin metilasyon oranı ALL hastalarında sağlıklı kontroller göre daha yüksekti.Sonuç: Hastaların yıllar süren takibi sonucunda VEGF-C ve bFGF'de farklı zaman aralıklarında uzun süreli değişiklikler hastalık riski ile daha güçlü ilişkiler gösterebilir. Hem VEGF-C hem de bFGF ve ALL risk faktörleri ile güçlü bağlantılar kurmak için daha ileri çalışmalara ihtiyaç vardır.

🔖

Cite This Article

İNANDIKLIOGLU, N., DEMİRHAN, O., BAYRAM, İ., TANYELİ, A. (2020). Plasma expression and methylation levels of vascular endothelial growth factor (VEGF-C) and basic fibroblast growth factor (bFGF) in children with acute lymphoblastic leukemia in Çukurova Region, Turkey. Cukurova Medical Journal, Cilt: 45 - Sayı: 2, 581–587. https://ajindex.com/articles/56180

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Moehler TM, Ho AD, Goldschmidt H, Barlogie B. Angiogenesis in hematologic malignancies. Crit Rev Oncol Hematol. 2003;45:227-44
  2. Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol. 2005;23:1011-27
  3. Aguayo A, Estey E, Kantarjian H, Mansouri T, Gidel C, Keating M et al. Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia. Blood. 1999;94:3717-21
  4. Salven P, Orpana A, Teerenhovi L, Joensuu H. Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in nonHodgkin lymphoma: a single-institution study of 200 patients. Blood. 2000;96:3712-18
  5. Ribatti D, Scavelli C, Roccaro AM, Crivellato E, Nico B, Vacca A. Hematopoietic cancer and angiogenesis. Stem Cells Dev. 2004;13:484-95
  6. Podar K, Anderson KC. The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications. Blood. 2005;105:1383–95
  7. Faderl S, Do KA, Johnson MM, Keating M, O'brien S, Jilani I et al. Angiogenic factors may have a different prognostic role in adult acute lymphoblastic leukemia. Blood. 2005;106:4303-07
  8. Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med. 2001;7:192-8
  9. Dias S, Choy M, Alitalo K, Rafii S. Vascular endothelial growth factor (VEGF)-C signaling through FLT-4(VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy. Blood. 2002;99:2179-84
  10. Perez-Atayde AR, Sallan SE, Tedrow U, Connors S, Allred E, Folkman J. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol. 1997;150:815- 21
  11. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med. 1985;103:620- 5
  12. Rothe G. Schmitz G. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis. Leukemia. 1996;10.5:877-95
  13. Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science. 1997;276:1423-25
  14. Makinen T, Jussila L, Veikkola T, Karpanen T, Kettunen